Trial intelligence / Profile preview

Anti-TNF agents vs tacrolimus as maintenance therapy in inactive rheumatoid arthritis on methotrexate

KCT0005868Phase 4Completed

Sponsor
Astellas Pharma
Start
Nov 2012
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of tacrolimus and methotrexate in rheumatoid arthritis (RA) (2 arms), sponsored by Astellas Pharma. Started Nov 2012; status: completed.

02

Drugs

tacrolimusmethotrexate
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on KCT0005868.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0005868.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call